Australia markets closed

Y-mAbs Therapeutics, Inc. (YMAB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
12.10+0.09 (+0.75%)
At close: 04:00PM EDT
12.10 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
84,499
84,819
65,267
34,897
20,750
-
Cost of revenue
11,480
11,416
7,567
2,514
2,203
-
Gross profit
73,019
73,403
57,700
32,383
18,547
-
Operating expenses
Research development
54,068
54,219
91,572
93,245
93,697
-
Selling general and administrative
44,030
44,856
60,939
54,571
44,785
-
Total operating expenses
98,098
99,075
152,511
147,816
138,482
-
Operating income or loss
-25,079
-25,672
-94,811
-115,433
-119,935
-
Interest expense
-
-
757
1,852
-
-
Total other income/expenses net
-
-
-
62,010
-
-
Income before tax
-20,945
-20,866
-95,568
-55,275
-119,337
-
Income tax expense
721
561
0
-
-
-
Income from continuing operations
-21,666
-21,427
-95,568
-55,275
-119,337
-
Net income
-21,666
-21,427
-95,568
-55,275
-119,337
-
Net income available to common shareholders
-21,666
-21,427
-95,568
-55,275
-119,337
-
Basic EPS
-0.45
-
-2.19
-1.28
-2.97
-2.30
Diluted EPS
-0.45
-
-2.19
-1.28
-2.97
-2.30
Basic average shares
43,656
-
43,704
43,182
40,119
35,183
Diluted average shares
43,656
-
43,704
43,182
40,119
35,183